FMR1: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
== FMR1 Gene == | |||
[[File:Fmr1.jpeg|thumb|right|The FMR1 gene is located on the X chromosome.]] | |||
The FMR1 gene is located on the | |||
The '''FMR1''' gene, also known as the '''fragile X mental retardation 1''' gene, is a gene located on the X chromosome at the position Xq27.3. It is responsible for producing a protein called [[FMRP]] (fragile X mental retardation protein), which is essential for normal cognitive development and functioning. | |||
The FMR1 gene | |||
== | === Function === | ||
The FMR1 gene encodes the [[FMRP]], which is an RNA-binding protein. FMRP is involved in the regulation of synaptic plasticity, which is crucial for learning and memory. It plays a role in the transport of mRNA from the nucleus to the cytoplasm and is involved in the regulation of protein synthesis at synapses. | |||
=== Genetic Structure === | |||
The FMR1 gene contains a region of [[CGG trinucleotide repeat]]s. In the normal population, this repeat is present in a range of 5 to 44 repeats. However, in individuals with fragile X syndrome, the number of repeats is significantly increased, often exceeding 200 repeats, leading to the silencing of the gene. | |||
=== Fragile X Syndrome === | |||
[[File:Fmr1.jpeg|thumb|left|FMR1 gene mutations can lead to fragile X syndrome.]] | |||
Fragile X syndrome is a genetic disorder caused by the expansion of the CGG trinucleotide repeat in the FMR1 gene. This expansion leads to the methylation and silencing of the gene, resulting in the absence or deficiency of FMRP. The lack of FMRP disrupts normal neural development, leading to intellectual disability, behavioral challenges, and various physical features associated with the syndrome. | |||
=== Premutation Carriers === | |||
Individuals with 55 to 200 CGG repeats in the FMR1 gene are considered premutation carriers. While they do not typically exhibit the full symptoms of fragile X syndrome, they may be at risk for other conditions such as fragile X-associated tremor/ataxia syndrome (FXTAS) and fragile X-associated primary ovarian insufficiency (FXPOI). | |||
== Related Pages == | |||
* [[Fragile X syndrome]] | * [[Fragile X syndrome]] | ||
* [[ | * [[Trinucleotide repeat disorder]] | ||
* [[ | * [[X-linked dominant inheritance]] | ||
* [[Genetic counseling]] | |||
{{Genetics-stub}} | |||
[[Category:Genetics]] | |||
[[Category:Genes on human chromosome X]] | [[Category:Genes on human chromosome X]] | ||
Latest revision as of 03:26, 13 February 2025
FMR1 Gene[edit]

The FMR1 gene, also known as the fragile X mental retardation 1 gene, is a gene located on the X chromosome at the position Xq27.3. It is responsible for producing a protein called FMRP (fragile X mental retardation protein), which is essential for normal cognitive development and functioning.
Function[edit]
The FMR1 gene encodes the FMRP, which is an RNA-binding protein. FMRP is involved in the regulation of synaptic plasticity, which is crucial for learning and memory. It plays a role in the transport of mRNA from the nucleus to the cytoplasm and is involved in the regulation of protein synthesis at synapses.
Genetic Structure[edit]
The FMR1 gene contains a region of CGG trinucleotide repeats. In the normal population, this repeat is present in a range of 5 to 44 repeats. However, in individuals with fragile X syndrome, the number of repeats is significantly increased, often exceeding 200 repeats, leading to the silencing of the gene.
Fragile X Syndrome[edit]

Fragile X syndrome is a genetic disorder caused by the expansion of the CGG trinucleotide repeat in the FMR1 gene. This expansion leads to the methylation and silencing of the gene, resulting in the absence or deficiency of FMRP. The lack of FMRP disrupts normal neural development, leading to intellectual disability, behavioral challenges, and various physical features associated with the syndrome.
Premutation Carriers[edit]
Individuals with 55 to 200 CGG repeats in the FMR1 gene are considered premutation carriers. While they do not typically exhibit the full symptoms of fragile X syndrome, they may be at risk for other conditions such as fragile X-associated tremor/ataxia syndrome (FXTAS) and fragile X-associated primary ovarian insufficiency (FXPOI).
